Search
MORE TO EXPLORE
Get expert insights and real-world perspectives from leading voices in the industry to help you make more informed decisions.
The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
Media & Resources
313 results for insulin costs
Novartis hiked its spending in the first quarter of 2019 by an eye-popping 450 percent to $3.2 million, up from $580,000.
The actions have raised questions about why it took public pressure before the companies altered their programs.
News from AmWINS, The Guardian Life Insurance Company of America, PreferredOne, The Standard, Wellbeats
CVS Health says it's tried offering drug plans without rebates, but consumers don't want them.
Politicians and Big Pharma find themselves in a tough spot as public pressure forces deeper digging into drug pricing policies.
Blue Cross Blue Shield is urging Congress to boost the ACA marketplace by increasing subsidies and putting in place a reinsurance program.
A coalition of Democrats is seeking to restore stability to the ACA, a more attainable vision than Medicare for All, but not without its challenges.
Is this bill so different from Medicare for All proposals that have come before? And why would those differences matter?
Executives expressed support for eliminating drug rebates, increasing price transparency and shifting to a more value-based pricing system.
Legislation proposed by Congressional Progressive Caucus co-chair Pramila Jayapal would steer all Americans into the Medicare program in two years.